NCT00958776.
Methods | A study to evaluate the efficacy and safety of IV peramivir in addition to standard of care compared to standard of care alone in adults and adolescents who are hospitalised due to influenza Sponsor: BioCryst Pharmaceuticals |
Participants | Peramivir |
Interventions | — |
Outcomes | — |
Notes | Awaiting assessment as we do not yet have the clinical study reports for this study |